[THE ALTERATION OF THE HYPERGLYCEMIC EFFECT OF MORPHINE BY OPIATE ANTAGONISTS AND OTHER DRUGS].
D056486:Chemical and Drug Induced Liver Injury; D004112:Dimercaprol; D004878:Ergotamine; D006506:Hepatitis A; D006943:Hyperglycemia; D007328:Insulin; D008112:Liver Glycogen; D009020:Morphine; D009269:Nalorphine; D009292:Narcotic Antagonists; D009388:Neostigmine; D010600:Pharmacology; D051381:Rats; D012106:Research; D014043:Tolazoline; D014044:Tolbutamide; D014116:Toxicology
D007328:Insulin; D008112:Liver Glycogen; D009292:Narcotic Antagonists; D004112:Dimercaprol; D009388:Neostigmine; D009020:Morphine; D014044:Tolbutamide; D014043:Tolazoline; D004878:Ergotamine; D009269:Nalorphine
DIMERCAPROL; ERGOTAMINE; EXPERIMENTAL LAB STUDY; HEPATITIS, TOXIC; HYPERGLYCEMIA; INSULIN; LIVER GLYCOGEN; MORPHINE; NALORPHINE; NARCOTIC ANTAGONISTS; NEOSTIGMINE; PHARMACOLOGY; RATS; TOLAZOLINE; TOLBUTAMIDE; TOXICOLOGIC REPORT
DIE BEEINFLUSSUNG DES HYPERGLYKAEMISCHEN MORPHINEFFEKTES DURCH OPIATANTAGONISTEN UND ANDERE PHARMAKA.